Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial-Reference-Cited by-同舟云学术

Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial

Published:2012-05 Issue:5 Volume:163 Page:835.e1-835.e7
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Biondi-Zoccai Giuseppe,Valgimigli Marco,Margheri Massimo,Marzocchi Antonio,Lettieri Corrado,Stabile Amerigo,Petronio A. Sonia,Binetti Giorgio,Bolognese Leonardo,Bellone Pietro,Sardella Gennaro,Contarini Marco,Sheiban Imad,Marra Sebastiano,Piscione Federico,Romeo Francesco,Colombo Antonio,Sangiorgi Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions;Karvouni;J Am Coll Cardiol,2003

2. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicenter randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting;Topol;Lancet,1999

3. Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention;O'Shea;JAMA,2002

4. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial;Kastrati;JAMA,2006

5. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel;Kastrati;N Engl J Med,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis;Cardiovascular Revascularization Medicine;2016-12

2. Parenteral Antiplatelet Agents in PCI;Interventional Cardiology;2016-11-19

3. Role of Parenteral Agents in PCI for Stable Patients;Interventional Cardiology;2016-11-19

4. Novel Anti-Platelets in Stable Coronary Artery Disease;Current Pharmaceutical Design;2016-09-02

5. Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions;European Heart Journal - Cardiovascular Pharmacotherapy;2015-12-11